HMGB1 and cancer: This study aimed to determine if HMGB1 would be released from human-derived cancer cells and normal cells after 131I-MIBG administration, with the goal of establishing useful radioimmunotherapy in the form of immunotherapy combined with 131I-MIBG, which has rarely been studied.